Report-store Details

  • Home
  • Report-store Details
Contact Us
+1 (732) 526 1166
India: 040-46013143

info@sciinovgroup.com

Email Us

Report Type: Industry Trends
Report Category: Regulatory Insights
Report Subcategory: 505 (b)2 Drugs
Price: 2999.00
Date: July 2021

505 (B) 2 Pathway: Drugs, Trials, Technology, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, and Manufacturing

505 (b)(2) Pathway:
The 505 (b)(2) pathway provides manufacturers who have certain types of drugs with an opportunity to acquire FDA approval without performing all the work that’s required with an NDA. These drugs are not strictly generics, but are often not entirely novel new molecular entities either. 505 (b)(2) can be an option for drugs with a new aspect related to indication, dosage form or regimen, strength, combination with other products, or other unique traits.

Have a business Query? Let's Talk.

Email : info@sciinovgroup.com or Call : +1 (732) 526 1166
India: 040-46013143

Get The Latest Updates

Signup For Newsletter

(c) 2021 Sciinov Group - All rights reserved.